By Jonathan Stempel NEW YORK, Dec 2 (Reuters) - CVS Health will pay $37.76 million to settle allegations it dispensed too ...

A record $37.8 million settlement closes a decade-long case alleging that CVS overbilled government health programs by ...

As part of the settlement, CVS admitted and accepted responsibility for certain conduct alleged by the government, including ...

CVS settles insulin dispensing case for $38M over improper billing to Medicare, Medicaid and federal health programs from 2010 to 2020.

California lawmakers and Gov. Gavin Newsom have approved more than 900 new laws that will begin to take effect starting on ...

CVS has settled a lawsuit for $37.76 million over claims of over-dispensing insulin pens and fraudulent billing.

For a decade, CVS knew it was skirting rules meant to limit overprescribing but did nothing to stop, according to the ...

Emerging research highlights vitamin D as a potential, overlooked factor in insulin resistance, a precursor to Type 2 ...

A compound that enables the delivery of insulin through the skin has been demonstrated in mice and minipigs. The findings, ...

A polymer can carry insulin through the skin and into the bloodstream, heralding a future where people with diabetes could ...

Cost is certainly the largest issue, but there are other barriers to accessing insulin that we need to address,” Yale School ...

Excessive sugar consumption can overwhelm your liver, leading to fat accumulation, inflammation, insulin resistance, and ...